TITLE

Medications That Don't Mix With Juices

AUTHOR(S)
Payne, January W.
PUB. DATE
September 2008
SOURCE
U.S. News & World Report;9/1/2008, Vol. 145 Issue 5, p92
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports that apple juice, orange juice, and grapefruit juice alter the transportation and absorption of certain medications inside the body. Comments from clinical pharmacology professor David Bailey regarding the risk of taking medications with juice are provided. Information is also included about the drugs which are negatively affected by juice, including statins, etoposide, and atenolol.
ACCESSION #
34081819

 

Related Articles

  • Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A-reductase inhibitors (statins). Igel, M.; Sudhop, T.; von Bergmann, K. // European Journal of Clinical Pharmacology;Aug2001, Vol. 57 Issue 5, p357 

    3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA)-reductase inhibitors (statins) are mainly considered for long-term use and often constitute part of a multiple-drug regime. Besides common adverse drug effects, such as nausea, abdominal discomfort and headaches, all statins harbour the risk of...

  • Factors Associated with Findings of Published Trials of DrugDrug Comparisons: Why Some Statins Appear More Efficacious than Others. Bero, Lisa; Oostvogel, Fieke; Bacchetti, Peter; Lee, Kirby // PLoS Medicine;Jun2007, Vol. 4 Issue 6, pe184 

    Lisa Bero and colleagues found published trials comparing one statin with another were more likely to report results and conclusions favoring the sponsor's product than the comparison drug.

  • Understanding adherence to official guidelines on statin prescribing in primary health care—a multi-level methodological approach. Ohlsson, H.; Lindblad, U.; Lithman, T.; Ericsson, B.; Gerdtham, U.-G.; Melander, A.; Råstam, L.; Merlo, J. // European Journal of Clinical Pharmacology;Oct2005, Vol. 61 Issue 9, p657 

    Objective: The aim was to investigate the role that municipalities and out-patient health care centres (HCCs) have in understanding adherence to official guidelines on statin prescribing. Our hypothesis was that after guideline publication, adherence to recommended statin prescription would...

  • Drugs That Lower the Risk of Stroke.  // Clarendon Enterprise (TX);10/16/2008, Vol. 19 Issue 41, p8 

    The article discusses statin-type cholesterol drugs.

  • Discontinuation of Statins in Routine Care Settings. Gnjidic, Danijela; Le Couteur, David G.; Hilmer, Sarah N.; de Groen, Piet C.; LeBlanc, Thomas W.; Kutner, Jean S.; Ritchie, Christine S.; Abernethy, Amy P.; Huabing Zhang; Plutzky, Jorge; Turchin, Alexander // Annals of Internal Medicine;7/2/2013, Vol. 159 Issue 1, p73 

    Several letters to the editor are presented in response to the article "Discontinuation of statins in routine care settings: a cohort study " in a 2013 issue along with a response from the authors of the article.

  • Confusion over statin script rules.  // Pulse;5/24/2004, Vol. 64 Issue 21, p1 

    Reports on the confusion over the policy of Great Britain National Health Service to make statins available over the counter.

  • Statin drug bans forcing GPs to offer 'sub-optimal care'. Anekwe, Lilian // Pulse;4/20/2011, Vol. 71 Issue 14, p3 

    The article reports on the research analysis which depicts that the use of atorsavatatin or rosuvatatin instead of simvastatin to treat patients with acute coronary syndrome is cost-effective and better care in Great Britain.

  • This Week in the Journal.  // New England Journal of Medicine;12/15/2011, Vol. 365 Issue 24, p2254 

    This section provides an overview of articles published within the issue including "The Risks and Benefits of Indacaterol," "Pragmatic Trials for Statin-Intolerant Patients" and "Dealing with Uncertainty in a Time of Plenty."

  • Eye on the Literature. Benner, J.S.; Glynn, R.J.; Mogun, H.; Moliterno, D.J.; Yakubov, S.J.; DiBattiste, P.M.; Olschewski, H.; Simmonneau, G.; Galie, N. // Formulary;Sep2002, Vol. 37 Issue 9, p447 

    Presents the published studies of interest to drug decision makers. Adherence of aged patients to statin therapy; Disappearance of difference in antiplatelet drug at six months; Effectiveness of iloprost.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics